These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 10390595

  • 1. Postoperative changes in thyrotropin-binding inhibitory immunoglobulin level in patients with Graves' disease: is subtotal thyroidectomy a suitable therapeutic option for patients of childbearing age with Graves' disease?
    Sugino K, Ito K, Ozaki O, Mimura T, Iwasaki H, Wada N.
    World J Surg; 1999 Jul; 23(7):727-31. PubMed ID: 10390595
    [Abstract] [Full Text] [Related]

  • 2. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
    Sugino K, Mimura T, Ozaki O, Iwasaki H, Wada N, Matsumoto A, Ito K.
    World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
    [Abstract] [Full Text] [Related]

  • 3. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

  • 4. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
    Mori Y, Matoba N, Miura S, Sakai N, Taira Y.
    World J Surg; 1992 Oct; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
    [Abstract] [Full Text] [Related]

  • 5. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N, Yamashiro K, Komiya I, Ochi Y, Sato Y, Nagata A.
    Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
    [Abstract] [Full Text] [Related]

  • 6. A prospective study of the changes in thyrotropin binding inhibitory immunoglobulins in Graves' disease treated by subtotal thyroidectomy or radioactive iodine.
    Teng CS, Yeung RT, Khoo RK, Alagaratnam TT.
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1005-10. PubMed ID: 6103007
    [Abstract] [Full Text] [Related]

  • 7. Changes in thyrotropin receptor antibody after subtotal thyroidectomy in Graves' disease: comparison with the degree of lymphocytic infiltration in the thyroid.
    Cho BY, Oh SK, Shong YK, Kim SE, Yoo HY, Lee HK, Koh CS, Min HK.
    Autoimmunity; 1990 Jun; 8(2):143-7. PubMed ID: 1983330
    [Abstract] [Full Text] [Related]

  • 8. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N, Oshiro C, Akamine H, Komiya I, Nagata A, Sato Y, Yoshimura H, Ito K.
    J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
    [Abstract] [Full Text] [Related]

  • 9. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W, Man N, Li YS, Shan ZY, Teng WP.
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [Abstract] [Full Text] [Related]

  • 10. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease.
    Kasuga Y, Kobayashi S, Fujimori M, Shingu K, Asanuma K, Hama Y, Ito K, Maruyama M, Amano J.
    Eur J Surg; 1998 Mar; 164(3):173-8. PubMed ID: 9562276
    [Abstract] [Full Text] [Related]

  • 11. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, Ito K.
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [Abstract] [Full Text] [Related]

  • 12. Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease.
    Okamoto T, Fujimoto Y, Obara T, Ito Y, Aiba M.
    World J Surg; 1992 Sep; 16(4):690-5; discussion 695-6. PubMed ID: 1413838
    [Abstract] [Full Text] [Related]

  • 13. Natural course of Graves' disease after subtotal thyroidectomy and management of patients with postoperative thyroid dysfunction.
    Kuma K, Matsuzuka F, Kobayashi A, Hirai K, Fukata S, Tamai H, Miyauci A, Sugawara M.
    Am J Med Sci; 1991 Jul; 302(1):8-12. PubMed ID: 1676563
    [Abstract] [Full Text] [Related]

  • 14. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
    Maugendre D, Massart C.
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
    [Abstract] [Full Text] [Related]

  • 15. Thyroid surgery for Graves' disease and Graves' ophthalmopathy.
    Liu ZW, Masterson L, Fish B, Jani P, Chatterjee K.
    Cochrane Database Syst Rev; 2015 Nov 25; 2015(11):CD010576. PubMed ID: 26606533
    [Abstract] [Full Text] [Related]

  • 16. Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease.
    Kasagi K, Tamai H, Morita T, Hidaka A, Hatabu H, Misaki T, Iida Y, Ishihara T, Ikekubo K, Kuma K.
    J Clin Endocrinol Metab; 1989 Jun 25; 68(6):1189-94. PubMed ID: 2566620
    [Abstract] [Full Text] [Related]

  • 17. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
    Khoo DH, Eng PH, Ho SC, Tai ES, Morgenthaler NG, Seah LL, Fong KS, Chee SP, Choo CT, Aw SE.
    Thyroid; 2000 Dec 25; 10(12):1093-100. PubMed ID: 11201855
    [Abstract] [Full Text] [Related]

  • 18. Relationship between thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins years after administration of radioiodine for Graves' disease: retrospective clinical survey.
    Yoshida K, Aizawa Y, Kaise N, Fukazawa H, Kiso Y, Sayama N, Mori K, Hori H, Abe K.
    J Endocrinol Invest; 1996 Nov 25; 19(10):682-6. PubMed ID: 9007700
    [Abstract] [Full Text] [Related]

  • 19. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
    Ochi Y, Hamazu M, Kajita Y, Nagata A.
    Clin Endocrinol (Oxf); 2002 Mar 25; 56(3):405-12. PubMed ID: 11940054
    [Abstract] [Full Text] [Related]

  • 20. Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease.
    Kim J, Choi MS, Park J, Park H, Jang HW, Choe JH, Kim JH, Kim JS, Cho YS, Choi JY, Kim TH, Chung JH, Kim SW.
    Thyroid; 2021 Aug 25; 31(8):1264-1271. PubMed ID: 33947272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.